Posted on May 12, 2017
Research by David L. Bartlett, MD was featured in the April 2017 University of Pittsburgh Cancer Institute (UPCI) video blog, “New Study Demonstrates Synergistic Anti-Cancer Effects of Oncolytic Virus Combined with Immune Checkpoint Inhibitor.”